Oura Delays $15 Billion IPO Amid Market Uncertainty

Oura has postponed its plan to sell shares on the US stock market, which would have valued the company at $15 billion, just days after the announcement. The maker of smart rings that track health stated it would delay its flotation due to uncertainty in the Initial Public Offering (IPO) market, without providing a timeline for when it might proceed. The company had filed documents to raise up to $2.2 billion by offering shares to investors just over a week ago. Oura's decision follows a trend of companies delaying public listings, with experts noting that the IPO market is becoming increasingly challenging. Oura's chief executive, Tom Hale, remarked that 'an IPO is just one step in our journey,' and stated that the company has the luxury of choosing its timing. Earlier this month, Holtec International, a US nuclear technology firm, also postponed its IPO, citing a combination of factors that have affected investor confidence, including rising energy costs, military conflicts, global trade tensions, and inflation concerns leading to increased interest rates by central banks like the US Federal Reserve. This week, the yield on US debt repayable in 10 years reached its highest level since 2007. Samuel Kerr, global head of equity capital markets at Mergermarket, noted that the current IPO market is significantly different from what was anticipated just weeks ago. Oura had intended to price its shares between $40 and $44 on the Nasdaq, which would have given the company an implied market value of $15 billion. For the financial year ending September 30, 2025, Oura reported a pre-tax profit of $23.5 million on sales of $907.8 million, compared to a pre-tax profit of $6.2 million the previous year. Its most recent figures for the nine months ending June 30 show a pre-tax income of $70 million on sales of $1.2 billion. Founded in Finland in 2013, Oura has its global headquarters in San Francisco and produces smart rings that cost upwards of $300, monitoring metrics such as heartbeat and sleep patterns through an app. The company is currently facing a class action lawsuit alleging false advertising regarding the accuracy of its sleep tracking claims. The lawsuit, filed by the Clarkson Law Firm in August, asserts that 'Oura rings cannot measure one's sleep or cycles.' However, Oura stated that its decision to delay the IPO is not related to the lawsuit and affirmed its confidence in its scientific claims regarding the product's functionality.